Approval · Notice of Compliance 25274 · 2021
CINRYZE: Notice of Compliance 25274
Issued February 22, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25274
- Date
- February 22, 2021
- Company
- Viropharma Biologics Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes tot he drug substance manufacturing process and addition of an alternate drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CINRYZE | Not yet assigned | — |
Medicinal ingredients
- C1 ESTERASE INHIBITOR (HUMAN) 500 UNIT per VIAL